U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07828964) titled 'The BRAVE (Behaviourally Responsive Assessments of Vital Signs in Emergency) Study' on July 24.

Brief Summary: This is a randomized, unblinded, single-centre, pilot feasibility study. A total of 100 patients will be enrolled and randomized to have their vital signs collected using either the Masimo Radius PPG and Radius T in combination with standard equipment, or only the standard equipment. Within the experimental group, Children will have their HR, RR, SpO2, and T measured using the wearable monitors, specifically the Masimo Radius PPG and Radius T devices that are attached to them wirelessly. Blood pressure (BP) will then be me...